Protagenic Therapeutics Announces Board and Executive Changes
Ticker: PTIXW · Form: 8-K · Filed: Jul 24, 2025 · CIK: 1022899
| Field | Detail |
|---|---|
| Company | Protagenic Therapeutics, Inc.\New (PTIXW) |
| Form Type | 8-K |
| Filed Date | Jul 24, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, executive-compensation
Related Tickers: PTIX
TL;DR
Protagenic Therapeutics shakes up board and exec pay. Big changes coming?
AI Summary
Protagenic Therapeutics, Inc. announced on July 18, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for key personnel. Specific dollar amounts and names of individuals involved in these changes are not detailed in the provided excerpt.
Why It Matters
Changes in a company's board and executive compensation can signal shifts in strategy, governance, or financial priorities, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in board composition and executive compensation can indicate internal shifts that may affect the company's future direction and stability.
Key Players & Entities
- Protagenic Therapeutics, Inc. (company) — Filer of the 8-K report
- July 18, 2025 (date) — Date of the earliest event reported
- July 24, 2025 (date) — Filing date of the 8-K report
- Atrinsic, Inc. (company) — Former company name
- NEW MOTION, INC. (company) — Former company name
- MPLC, Inc. (company) — Former company name
FAQ
What specific roles have been affected by the departure of officers or directors?
The filing indicates the departure of certain officers and directors, but does not specify their exact roles in the provided excerpt.
Who are the newly elected directors?
The filing states that new directors have been elected, but their names are not listed in the provided excerpt.
What are the details of the updated compensatory arrangements?
The filing mentions updates to compensatory arrangements for certain officers, but the specific details and amounts are not included in the provided excerpt.
When was the company previously known as Atrinsic, Inc.?
The company's name was changed from Atrinsic, Inc. on June 30, 2009.
What is the company's Standard Industrial Classification (SIC) code?
Protagenic Therapeutics, Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 24, 2025 regarding Protagenic Therapeutics, Inc.\new (PTIXW).